May 28, 2019
Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
March 26, 2019
A report by Cortellis says that seven drugs entering the market in 2019 are projected to reach blockbuster status by...
September 24, 2018
Alexion Pharmaceuticals (NASDAQ:ALXN) today announced positive topline results from the Phase 3 PREVENT study of Soliris (eculizumab) in patients with anti-aquaporin-4 (AQP4)...
June 28, 2018
Alexion Pharmaceuticals (NASDAQ:ALXN) announced the submission of a Marketing Authorization Application to the European Medicines Agency (EMA) for ALXN1210, the...
February 26, 2018
Investors and analysts are focusing on KemPharm and Achillion after both companies received recent positive regulatory news.
April 25, 2017
biOasis Technologies announced the appointment of Dr. Mark Day as president and CEO of the company.
March 19, 2017
Cerulean Pharma leads the list of last week's life science gainers on the NASDAQ, followed by Catalyst Pharmaceutical, Neovasc, Arbutus...